VANGUARD GROUP INC

Holdings History for X4 Pharmaceuticals, Inc - Common Stock (XFOR)

Symbol: XFOR on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 8.2M shares
Security Ownership: 4.8%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in X4 Pharmaceuticals, Inc Common Stock (XFOR)

2025-01-31 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.2M shares of X4 Pharmaceuticals, Inc Common Stock (XFOR). This represents 4.8% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	4.8%		$1.94M	8.2M			$0.24	13G/A	12/31/2024	31 Jan 2025 10:09:25

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0%	0%	$6.02M	8.2M	-239,827	-2.84%	$0.73	Q4 2024
9/30/2024	0%	+0%	$5.65M	8.44M	+150,680	+1.82%	$0.67	Q3 2024
6/30/2024	0%	+0%	$4.81M	8.29M	+462,323	+5.91%	$0.58	Q2 2024
3/31/2024	0%	0%	$10.9M	7.83M	-181,138	-2.26%	$1.39	Q1 2024
12/31/2023	0%	+0%	$6.72M	8.01M	+184,148	+2.35%	$0.84	Q4 2023
9/30/2023	0%	+0%	$8.53M	7.82M	+37,577	+0.48%	$1.09	Q3 2023
6/30/2023	0%	+0%	$15.1M	7.79M	+3,442,829	+79.2%	$1.94	Q2 2023
3/31/2023	0%	+0%	$3.78M	4.34M	+763,922	+21.3%	$0.87	Q1 2023
12/31/2022	0%	+0%	$3.56M	3.58M	+372,286	+11.6%	$0.99	Q4 2022
9/30/2022	0%	+0%	$5.49M	3.21M	+2,492,928	+349%	$1.71	Q3 2022
6/30/2022	0%	+0%	$690K	715K	+61,990	+9.49%	$0.96	Q2 2022
3/31/2022	0%	0%	$1.14M	653K	-280,055	-30%	$1.75	Q1 2022
12/31/2021	0%		$2.14M	933K	-1,112	-0.12%	$2.29	Q4 2021
9/30/2021	0%	+0%	$4.94M	934K	+36,711	+4.09%	$5.29	Q3 2021
6/30/2021	0%	+0%	$5.83M	898K	+161,039	+21.9%	$6.50	Q2 2021
3/31/2021	0%		$6.34M	737K			$8.61	Q1 2021
12/31/2020	0%	+0%	$4.73M	735K	+17,574	+2.45%	$6.43^*	Q4 2020
9/30/2020	0%	0%	$4.86M	717K	-3,233	-0.45%	$6.77^*	Q3 2020
6/30/2020	0%	0%	$6.72M	721K	-18,423	-2.49%	$9.32	Q2 2020
3/31/2020	0%	+0%	$7.39M	739K	+18,362	+2.55%	$10.00	Q1 2020
12/31/2019	0%	+0%	$7.71M	721K	+178,761	+33%	$10.70	Q4 2019
9/30/2019	0%	+0%	$6.89M	542K	+19,114	+3.66%	$12.71	Q3 2019
6/30/2019	0%	+0%	$7.84M	523K	+436,539	+506%	$15.00	Q2 2019
3/31/2019	0%	+0%	$1.5M	86.3K	+86,272	NEW	$17.41	Q1 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.